Recombinant Protein Therapeutics Market Report

China Recombinant Protein Therapeutics Industry Market Research Report 2023-2029

  • POSTDATE：Aug 26, 2023
  • PAGES：163
  • REPORT CODE：GMM1757227
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Recombinant Protein Therapeutics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Ligand

    • Eli Lilly

    • Merck

    • Bayer

    • Roche

    • Biogen

    • Pfizer

    • Sanofi

    • J&J

    By Type:

    • Interferons

    • Hematopoietic Growth Factors

    • Others

    • Recombinant Hormones

    • Interleukins

    By Application:

    • Diabetes

    • Cancer

    • Dwarfism

    • Others

    • Heart Disease

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Recombinant Protein Therapeutics Market Overview 2018-2029

    • 1.1 China Recombinant Protein Therapeutics Industry Development Overview

    • 1.2 China Recombinant Protein Therapeutics Industry Development History

    • 1.3 China Recombinant Protein Therapeutics Industry Market Size (2018-2029)

    • 1.4 China Recombinant Protein Therapeutics Market Analysis by Type from Production Side

      • 1.4.1 China Recombinant Protein Therapeutics Production Volume, Production Value and Growth Rate of Interferons (2018-2029)

      • 1.4.2 China Recombinant Protein Therapeutics Production Volume, Production Value and Growth Rate of Hematopoietic Growth Factors (2018-2029)

      • 1.4.3 China Recombinant Protein Therapeutics Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.4 China Recombinant Protein Therapeutics Production Volume, Production Value and Growth Rate of Recombinant Hormones (2018-2029)

      • 1.4.5 China Recombinant Protein Therapeutics Production Volume, Production Value and Growth Rate of Interleukins (2018-2029)

    • 1.5 China Recombinant Protein Therapeutics Market Analysis by Application from Consumption End

      • 1.5.1 China Recombinant Protein Therapeutics Sales Volume, Sales Value and Growth Rate of Diabetes (2018-2029)

      • 1.5.2 China Recombinant Protein Therapeutics Sales Volume, Sales Value and Growth Rate of Cancer (2018-2029)

      • 1.5.3 China Recombinant Protein Therapeutics Sales Volume, Sales Value and Growth Rate of Dwarfism (2018-2029)

      • 1.5.4 China Recombinant Protein Therapeutics Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.5 China Recombinant Protein Therapeutics Sales Volume, Sales Value and Growth Rate of Heart Disease (2018-2029)

    • 1.6 China Recombinant Protein Therapeutics Market Analysis by Region

      • 1.6.1 North China Recombinant Protein Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Recombinant Protein Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Recombinant Protein Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Recombinant Protein Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Recombinant Protein Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Recombinant Protein Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Recombinant Protein Therapeutics Market Size and Growth Rate from 2018-2029

    Chapter 2 China Recombinant Protein Therapeutics Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Recombinant Protein Therapeutics Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Recombinant Protein Therapeutics Market Status and Competition Analysis in 2023

      • 2.2.3 China Recombinant Protein Therapeutics Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Recombinant Protein Therapeutics Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Recombinant Protein Therapeutics Industry Development

    Chapter 3 Recombinant Protein TherapeuticsIndustry Chain Analysis

    • 3.1 Recombinant Protein Therapeutics Industry Chain

    • 3.2 Recombinant Protein Therapeutics Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Recombinant Protein Therapeutics Market

    • 3.3 Recombinant Protein Therapeutics Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Recombinant Protein Therapeutics Market

    Chapter 4 China Recombinant Protein Therapeutics Market, by Type

    • 4.1 China Recombinant Protein Therapeutics Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Recombinant Protein Therapeutics Total Production Volume and Growth Rate from Production Side

    • 4.5 China Recombinant Protein Therapeutics Production Volume and Growth Rate, by Type

      • 4.5.1 China Recombinant Protein Therapeutics Production Volume and Growth Rate of Interferons

      • 4.5.2 China Recombinant Protein Therapeutics Production Volume and Growth Rate of Hematopoietic Growth Factors

      • 4.5.3 China Recombinant Protein Therapeutics Production Volume and Growth Rate of Others

      • 4.5.4 China Recombinant Protein Therapeutics Production Volume and Growth Rate of Recombinant Hormones

      • 4.5.5 China Recombinant Protein Therapeutics Production Volume and Growth Rate of Interleukins

    Chapter 5 China Recombinant Protein Therapeutics Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Recombinant Protein Therapeutics Total Market Size and Growth Rate from Consumption End

    • 5.5 China Recombinant Protein Therapeutics Market Size and Growth Rate, by Application

      • 5.5.1 China Recombinant Protein Therapeutics Market Size and Growth Rate of Diabetes

      • 5.5.2 China Recombinant Protein Therapeutics Market Size and Growth Rate of Cancer

      • 5.5.3 China Recombinant Protein Therapeutics Market Size and Growth Rate of Dwarfism

      • 5.5.4 China Recombinant Protein Therapeutics Market Size and Growth Rate of Others

      • 5.5.5 China Recombinant Protein Therapeutics Market Size and Growth Rate of Heart Disease

    Chapter 6 China Recombinant Protein Therapeutics Market, by Region

    • 6.1 China Recombinant Protein Therapeutics Production Volume and Production Value, by Region

    • 6.2 China Recombinant Protein Therapeutics Sales Volume and Sales Value, by Region

    Chapter 7 North China Recombinant Protein Therapeutics Market Analysis

    • 7.1 North China Recombinant Protein Therapeutics Market, by Type

    • 7.2 North China Recombinant Protein Therapeutics Market, by Application

    Chapter 8 Central China Recombinant Protein Therapeutics Market Analysis

    • 8.1 Central China Recombinant Protein Therapeutics Market, by Type

    • 8.2 Central China Recombinant Protein Therapeutics Market, by Application

    Chapter 9 South China Recombinant Protein Therapeutics Market Analysis

    • 9.1 South China Recombinant Protein Therapeutics Market, by Type

    • 9.2 South China Recombinant Protein Therapeutics Market, by Application

    Chapter 10 East China Recombinant Protein Therapeutics Market Analysis

    • 10.1 East China Recombinant Protein Therapeutics Market, by Type

    • 10.2 East China Recombinant Protein Therapeutics Market, by Application

    Chapter 11 Northeast China Recombinant Protein Therapeutics Market Analysis

    • 11.1 Northeast China Recombinant Protein Therapeutics Market, by Type

    • 11.2 Northeast China Recombinant Protein Therapeutics Market, by Application

    Chapter 12 Southwest China Recombinant Protein Therapeutics Market Analysis

    • 12.1 Southwest China Recombinant Protein Therapeutics Market, by Type

    • 12.2 Southwest China Recombinant Protein Therapeutics Market, by Application

    Chapter 13 Northwest China Recombinant Protein Therapeutics Market Analysis

    • 13.1 Northwest China Recombinant Protein Therapeutics Market, by Type

    • 13.2 Northwest China Recombinant Protein Therapeutics Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Ligand

        • 14.1.1 Ligand Company Profile

        • 14.1.2 Ligand Recombinant Protein Therapeutics Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Eli Lilly

        • 14.2.1 Eli Lilly Company Profile

        • 14.2.2 Eli Lilly Recombinant Protein Therapeutics Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Merck

        • 14.3.1 Merck Company Profile

        • 14.3.2 Merck Recombinant Protein Therapeutics Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Bayer

        • 14.4.1 Bayer Company Profile

        • 14.4.2 Bayer Recombinant Protein Therapeutics Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Roche

        • 14.5.1 Roche Company Profile

        • 14.5.2 Roche Recombinant Protein Therapeutics Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Biogen

        • 14.6.1 Biogen Company Profile

        • 14.6.2 Biogen Recombinant Protein Therapeutics Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Pfizer

        • 14.7.1 Pfizer Company Profile

        • 14.7.2 Pfizer Recombinant Protein Therapeutics Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Sanofi

        • 14.8.1 Sanofi Company Profile

        • 14.8.2 Sanofi Recombinant Protein Therapeutics Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 J&J

        • 14.9.1 J&J Company Profile

        • 14.9.2 J&J Recombinant Protein Therapeutics Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Recombinant Protein Therapeutics Industry Research Conclusions

    • 15.2 Recombinant Protein Therapeutics Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Recombinant Protein Therapeutics Industry Market Size (2018-2029)

    • Figure China Recombinant Protein Therapeutics Production Volume, Production Value and Growth Rate of Interferons (2018-2029)

    • Figure China Recombinant Protein Therapeutics Production Volume, Production Value and Growth Rate of Hematopoietic Growth Factors (2018-2029)

    • Figure China Recombinant Protein Therapeutics Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Recombinant Protein Therapeutics Production Volume, Production Value and Growth Rate of Recombinant Hormones (2018-2029)

    • Figure China Recombinant Protein Therapeutics Production Volume, Production Value and Growth Rate of Interleukins (2018-2029)

    • Figure China Recombinant Protein Therapeutics Sales Volume, Sales Value and Growth Rate of Diabetes (2018-2029)

    • Figure China Recombinant Protein Therapeutics Sales Volume, Sales Value and Growth Rate of Cancer (2018-2029)

    • Figure China Recombinant Protein Therapeutics Sales Volume, Sales Value and Growth Rate of Dwarfism (2018-2029)

    • Figure China Recombinant Protein Therapeutics Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Recombinant Protein Therapeutics Sales Volume, Sales Value and Growth Rate of Heart Disease (2018-2029)

    • Figure North China Recombinant Protein Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Central China Recombinant Protein Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure South China Recombinant Protein Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure East China Recombinant Protein Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Recombinant Protein Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Recombinant Protein Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Recombinant Protein Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Recombinant Protein Therapeutics Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Recombinant Protein Therapeutics Market Share by Type in 2018

    • Figure China Recombinant Protein Therapeutics Market Share by Type in 2023

    • Figure China Recombinant Protein Therapeutics Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Recombinant Protein Therapeutics Production Volume and Growth Rate of Interferons (2018-2023)

    • Figure China Recombinant Protein Therapeutics Production Volume and Growth Rate of Hematopoietic Growth Factors (2018-2023)

    • Figure China Recombinant Protein Therapeutics Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Recombinant Protein Therapeutics Production Volume and Growth Rate of Recombinant Hormones (2018-2023)

    • Figure China Recombinant Protein Therapeutics Production Volume and Growth Rate of Interleukins (2018-2023)

    • Figure China Recombinant Protein Therapeutics Market Share by Application in 2018

    • Figure China Recombinant Protein Therapeutics Market Share by Application in 2023

    • Figure China Recombinant Protein Therapeutics Total Market Size and Growth Rate from Consumption End

    • Figure China Recombinant Protein Therapeutics Market Size and Growth Rate of Diabetes (2018-2023)

    • Figure China Recombinant Protein Therapeutics Market Size and Growth Rate of Cancer (2018-2023)

    • Figure China Recombinant Protein Therapeutics Market Size and Growth Rate of Dwarfism (2018-2023)

    • Figure China Recombinant Protein Therapeutics Market Size and Growth Rate of Others (2018-2023)

    • Figure China Recombinant Protein Therapeutics Market Size and Growth Rate of Heart Disease (2018-2023)

    • Table China Recombinant Protein Therapeutics Production Volume by Region (2018-2023)

    • Table China Recombinant Protein Therapeutics Production Volume Share by Region (2018-2023)

    • Figure China Recombinant Protein Therapeutics Production Volume Share by Region (2018-2023)

    • Table China Recombinant Protein Therapeutics Production Value by Region (2018-2023)

    • Table China Recombinant Protein Therapeutics Production Value Share by Region (2018-2023)

    • Figure China Recombinant Protein Therapeutics Production Value Share by Region (2018-2023)

    • Table China Recombinant Protein Therapeutics Sales Volume by Region (2018-2023)

    • Table China Recombinant Protein Therapeutics Sales Volume Share by Region (2018-2023)

    • Figure China Recombinant Protein Therapeutics Sales Volume Share by Region (2018-2023)

    • Table China Recombinant Protein Therapeutics Sales Value by Region (2018-2023)

    • Table China Recombinant Protein Therapeutics Sales Value Share by Region (2018-2023)

    • Figure China Recombinant Protein Therapeutics Sales Value Share by Region (2018-2023)

    • Table North China Recombinant Protein Therapeutics Production Volume by Type (2018-2023)

    • Table North China Recombinant Protein Therapeutics Production Volume Share by Type (2018-2023)

    • Figure North China Recombinant Protein Therapeutics Production Volume Share by Type (2018-2023)

    • Table North China Recombinant Protein Therapeutics Sales Volume by Application (2018-2023)

    • Table North China Recombinant Protein Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure North China Recombinant Protein Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Central China Recombinant Protein Therapeutics Production Volume by Type (2018-2023)

    • Table Central China Recombinant Protein Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Central China Recombinant Protein Therapeutics Production Volume Share by Type (2018-2023)

    • Table Central China Recombinant Protein Therapeutics Sales Volume by Application (2018-2023)

    • Table Central China Recombinant Protein Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Central China Recombinant Protein Therapeutics Sales Volume Share by Application (2018-2023)

    • Table South China Recombinant Protein Therapeutics Production Volume by Type (2018-2023)

    • Table South China Recombinant Protein Therapeutics Production Volume Share by Type (2018-2023)

    • Figure South China Recombinant Protein Therapeutics Production Volume Share by Type (2018-2023)

    • Table South China Recombinant Protein Therapeutics Sales Volume by Application (2018-2023)

    • Table South China Recombinant Protein Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure South China Recombinant Protein Therapeutics Sales Volume Share by Application (2018-2023)

    • Table East China Recombinant Protein Therapeutics Production Volume by Type (2018-2023)

    • Table East China Recombinant Protein Therapeutics Production Volume Share by Type (2018-2023)

    • Figure East China Recombinant Protein Therapeutics Production Volume Share by Type (2018-2023)

    • Table East China Recombinant Protein Therapeutics Sales Volume by Application (2018-2023)

    • Table East China Recombinant Protein Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure East China Recombinant Protein Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Northeast China Recombinant Protein Therapeutics Production Volume by Type (2018-2023)

    • Table Northeast China Recombinant Protein Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Northeast China Recombinant Protein Therapeutics Production Volume Share by Type (2018-2023)

    • Table Northeast China Recombinant Protein Therapeutics Sales Volume by Application (2018-2023)

    • Table Northeast China Recombinant Protein Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Recombinant Protein Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Southwest China Recombinant Protein Therapeutics Production Volume by Type (2018-2023)

    • Table Southwest China Recombinant Protein Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Southwest China Recombinant Protein Therapeutics Production Volume Share by Type (2018-2023)

    • Table Southwest China Recombinant Protein Therapeutics Sales Volume by Application (2018-2023)

    • Table Southwest China Recombinant Protein Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Recombinant Protein Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Northwest China Recombinant Protein Therapeutics Production Volume by Type (2018-2023)

    • Table Northwest China Recombinant Protein Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Northwest China Recombinant Protein Therapeutics Production Volume Share by Type (2018-2023)

    • Table Northwest China Recombinant Protein Therapeutics Sales Volume by Application (2018-2023)

    • Table Northwest China Recombinant Protein Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Recombinant Protein Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Ligand Company Profile

    • Table Ligand Recombinant Protein Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly Company Profile

    • Table Eli Lilly Recombinant Protein Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Merck Company Profile

    • Table Merck Recombinant Protein Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Bayer Company Profile

    • Table Bayer Recombinant Protein Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Roche Company Profile

    • Table Roche Recombinant Protein Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Biogen Company Profile

    • Table Biogen Recombinant Protein Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Recombinant Protein Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Sanofi Company Profile

    • Table Sanofi Recombinant Protein Therapeutics Revenue, Price and Gross (2018-2023)

    • Table J&J Company Profile

    • Table J&J Recombinant Protein Therapeutics Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US